Influence of the Status of the Renin-Angiotensin System on the Effect of Cilazapril on Neointima Formation After Vascular Injury in Rats R ecently, it has been shown that one important risk factor for the occurrence of sudden death in hypertensive patients was the plasma renin level.' One hypothesis to explain this finding was that an increase of plasma renin could lead to an increased production of angiotensin II. Angiotensin II would then induce proliferation of smooth muscle cells in the arterial wall and thus promote accelerated development of arteriosclerosis. ' The possible deleterious effect of angiotensin II was also suggested by the fact that angiotensin converting enzyme (ACE) inhibition2'3 or angiotensin II receptor blockade3 could prevent myointimal proliferation after vascular injury. Interestingly, the effect of ACE inhibition did not seem to be mediated by a decrease of arterial pressure, since a similar decrease of arterial pressure induced by verapamil did not prevent neointima formation.2 Recently, however, a major clinical trial (MERCATOR) evaluating the effects of ACE inhibition with cilazapril on restenosis showed negative results.4 One possible explanation for this negative result could be a different status of the renin-angiotensin system (RAS) between humans and rats. In addition, a recent experimental study suggests that the effect of ACE inhibition on neointima formation was not due to the decrease of formation of angiotensin II but to the accumulation of bradykinin, which is degraded by ACE.5 Therefore, it was important to evaluate the influence of the RAS status on the effect of cilazapril.
Several models of hypertension have been described, and their relation to the RAS has been well characterized. 6 The two-kidney, one-clip (2K1C) model is a hypertension model with an initial high plasma renin level followed by a further normalization of the plasma renin level associated with a sustained overexpression of the tissular RAS.7-9 The deoxycorticosterone (DOCA) model is characterized by a very low plasma renin level.10 Spontaneously hypertensive rats have a normal or rather low plasma renin level.1"12 The goal of the present study was to evaluate whether the neointima formation induced by vascular injury was influenced by different hypertension models with different levels of stimulation of the RAS and whether ACE inhibition with cilazapril had similar effects on neointima formation in hypertension models with or without stimulation of the RAS. Methods
Renal hypertensive rats (Goldblatt type 2K1C) were produced by the following procedure: 6-week-old male normotensive rats were anesthetized with ether, and the left renal artery was clamped with a silver clip (slit width, 0.22 mm). The right renal artery was left intact. In another group of normotensive rats (sham operated), the same surgical procedure was performed without implantation of a clip. Rats were used 6 weeks after surgery for the experiment.
DOCA-NaCl-hypertensive rats were prepared as follows: 7-week-old male normotensive rats, which were subjected to unilateral nephrectomy under ether anesthesia, received a subcutaneous implant of 25 Arterial pressure and heart rate were measured indirectly by a tail-cuff plethysmographic technique. 13 
Vascular Injury
Endothelial denudation and vascular injury were achieved in the left common carotid artery of normotensive rats, as described.14 A balloon catheter (2F Fogarty, Edwards Laboratories, Santa Anna, Calif) was passed through the external carotid into the aorta; the balloon was inflated with sufficient water to distend the common carotid and was then pulled back to the external carotid. This procedure was repeated three times, and the catheter then was removed. Complete denudation of the endothelium was achieved throughout the common carotid, with some injury to medial smooth muscle cells, as assessed by morphological examination of random control rats 24 hours after the procedure. The rate of intimal thickening in the rat carotid in response to balloon injury slows considerably after 14 days.14 Therefore, at 14 days the animals were anesthetized and perfusion-fixed as described,14 with the modification that 2.5% glutaraldehyde and 90 mm Hg perfusion pressure were used. Carotid arteries were isolated from adherent tissue and embedded in Epon 812. Semithin sections (=1 ,Lm) were stained with toluidine blue and basic fuchsin and processed for morphometric evaluation.15,'6 Sections from the middle fifth of the carotid were analyzed, with the right carotid serving as a control 
Results

Arterial Pressure
Arterial pressure was significantly increased in the SHR, DOCA, and 2K1C rats compared with normotensive WKY rats (Fig 1) . Sham operation had no effect on blood pressure (Fig 1) . Under treatment with cilazapril, arterial pressure dramatically decreased in the SHR and 2K1C rats and much less in the DOCA rats (Fig 1 and  Table) . Cilazapril also slightly decreased arterial pressure in the normotensive WKY rats.
Effects of Vascular Injury in the Experimental Models
Neointima formation was increased only in SHR compared with normotensive WKY rats (see Table) . Neointima formation was not increased in the 2K1C rats (compared with control WKY without or with sham operation). Neointima formation was decreased in DOCA rats compared with normotensive WKY rats.
Vascular Effects of Cilazapril in the Experimental Models
Cilazapril was effective in reducing neointima formation in every group of rats except the DOCA rats (see Table) . This effect of cilazapril was observed when the neointima was expressed as absolute value or as a percentage of the media area. Despite the short treatment period, cilazapril significantly decreased the area of the media (both ballooned and unballooned arteries) only in SHR and 2K1C rats. Biochemical Characterization of the RAS During the 6 weeks of renal stenosis and DOCA administration, arterial pressure increased (Fig 2) . During the same period, arterial pressure stayed normal in the normotensive rats and increased in the spontaneously hypertensive rats (Fig 2) . Plasma Ballooning was performed at 6 weeks.
not change in normotensive rats and increased slightly in spontaneously hypertensive rats. Renal stenosis markedly increased plasma renin activity, which peaked at 1 week after renal artery stenosis and decreased progressively (Fig 3) . Administration of DOCA decreased plasma renin activity to unmeasurable levels (Fig 3) . Discussion The results of the study show that the effect of cilazapril on neointima formation after vascular injury strongly depends on the status of the RAS. In DOCAhypertensive rats with a low plasma renin activity, cilazapril did not prevent neointima formation after vascular injury.
It is extremely difficult to evaluate the status of the RAS using plasma renin activity. It is well known that after a stimulus such as renal stenosis, the plasma renin activity increases and then tends to come back to baseline despite the fact that blood pressure stays increased due to a stimulation of components of the RAS present in tissues.7-9 In DOCA rats, plasma renin activity is decreased.'0 In SHR, plasma renin activity is normal or low,",'2 but many studies have reported an increase of the component of the RAS in tissues. '7-20 Our biochemical results confirm that we have used a high plasma renin model (2K1C rats) and a low plasma renin model (DOCA rats), but we have no information on the status of the RAS in tissues.
The present results do not support a role for the accumulation of bradykinin in the preventive effect of cilazapril. Cilazapril was ineffective in DOCA rats, in which, to our knowledge, only the RAS and not the bradykinin system is suppressed. Our results also show that arterial pressure alone does not substantially influence neointima formation after vascular injury. Despite the increased arterial pressure, 2K1C rats did not have a larger neointima after ballooning. DOCA-hypertensive rats had a smaller neointima compared with normotensive rats. This confirms our previous findings showing that verapamil at a dose decreasing arterial pressure to the same extent as cilazapril did not influence neointima formation.2 Moreover, DOCA is a mineralocorticoid. To our knowledge, in contrast with glucocorticoid, this type of drug has not been shown to influence neointima formation.
In the present study, one of the main determinants of the effect of cilazapril on neointima formation appeared to be the status of the RAS. As described before, cilazapril was very effective in preventing neointima formation in normotensive rats and in 2K1C rats in which the RAS is stimulated. However, cilazapril was ineffective in the DOCA rats, in which the RAS is inhibited. The last finding of our study was the fact that for a similarly elevated arterial pressure, neointima formation was larger in SHR rats compared with DOCA and 2K1C rats. It is known that neointima formation is increased in SHR compared with normotensive rats. 32, 33 This was attributed to the high blood pressure,32 '33 which does not seem to be the case in our study with DOCA or 2K1C rats. In vitro, it has been shown clearly that smooth muscle cells of SHR grow faster than smooth muscle cells of normotensive rats, pointing to differences of phenotype.34-37 Our study would suggest that in vivo, this difference is also present. However, it is not possible to exclude a role of the RAS in the increase of neointima formation after vascular injury compared with normotensive rats (also SHR). SHR rats have a normal or low plasma renin activity but an increased tissular expression of the RAS. [16] [17] [18] [19] It is also important to note that DOCA rats did not have an increased response to vascular injury despite the threefold increase of TGF-13 mRNA37 or platelet-derived growth factor-a receptor mRNA level38 that has been shown in these rats. These results suggest that growth factors involved in medial thickening due to hypertension are different from those involved in vascular response to injury.
Clinical Relevance
The large multicenter trial MERCATOR, which had evaluated the effect of cilazapril on the prevention of restenosis, showed negative results. Several hypotheses can explain these could have been insufficient, cilazapril should have been given before angioplasty, or coronary spasm has masked the effect of cilazapril. However, the present study suggests that the effect of cilazapril is closely dependent on the RAS status. Thus, normotensive rats could have an RAS that is much more stimulated than that in humans. Differences of status of the RAS also could explain why cilazapril seems ineffective in other animal species such as pigs39 or monkeys,40 which points to the necessity of using several animal species for testing drugs that may prevent neointima formation after vascular injury.
